Loading...
Domestic
Equity
Passive

KBSTAR Healthcare (253280)

Update : 2024.02.21

NAV

13,136KRW

+43.34상승 (0.33%)

Market Price per share (KRW)

13,160KRW

+45상승 (0.34%)

※ t-1 last price

trading volume

3,575shares

AUM

KRW 7.8billion

KBSTAR Healthcare (253280)

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2024.02.21
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB KStar V&S Select ValueETF(Equity)
(253280)
FnGuide HealthCare Index 2016.09.23 50,000 7,881,347,997
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 13,160
※ t-1 last price
13,135 3,575
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency 다운로드 버튼
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB KStar V&S Select ValueETF(Equity)

(253280)
FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
7,881,347,997 하나은행
Market Price per share (KRW) iNAV per share (KRW)
13,160
※ t-1 last price
13,135
Trading Volume (shares)
3,575
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2024-02-21
Rank , Name, proportion table
Rank Name Weight (%)
1 HLB 17.37
2 SAMSUNG BIOLOGICS 10.34
3 Celltrion 8.68
4 Yuhan 7.47
5 HanmiPharm 5.31
6 SKBP 4.97
7 Celltrionph 4.00
8 SKBS 2.83
9 HANALL BIOPHARMA 2.56
10 Hanmi Science 2.37

proportion by sectors

*The proportion of investment stocks

Update : 2024.02.21
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2023-04-28 2023-05-03 16
2022-04-29 2022-05-03 60
2021-04-30 2021-05-04 71
2020-04-29 2020-05-06 46

Performance

performance

excel download

Update : 2024-02-21

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV 10.53 17.91 17.33 22.40 -20.89 1.64 29.32
Benchmark Index 10.66 17.88 17.27 22.43 -21.16 1.69 30.00
Outperformance -0.14 0.03 0.05 -0.04 0.26 -0.06 -0.68

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2024.02.20 13,160 0.343상승 13,135.58 0.331상승
2024.02.19 13,115 2.380상승 13,092.24 2.280상승
2024.02.16 12,810 0.786상승 12,800.37 0.889상승
2024.02.15 12,710 -0.935하락 12,687.57 -0.969하락
2024.02.14 12,830 -1.307하락 12,811.8 -1.642하락
2024.02.13 13,000 2.000상승 13,025.8 2.466상승
2024.02.08 12,745 -0.468하락 12,712.5 -0.696하락
2024.02.07 12,805 -0.039하락 12,801.64 0.076상승
2024.02.06 12,810 1.425상승 12,791.81 1.415상승
2024.02.05 12,630 -0.590하락 12,613.25 -1.048하락
2024.02.02 12,705 2.418상승 12,747.04 2.949상승
2024.02.01 12,405 -1.076하락 12,381.82 -1.329하락
2024.01.31 12,540 -1.839하락 12,548.71 -1.641하락
2024.01.30 12,775 1.752상승 12,758.07 1.692상승
2024.01.29 12,555 -0.159하락 12,545.73 -0.173하락
2024.01.26 12,575 2.862상승 12,567.64 2.850상승
2024.01.25 12,225 1.284상승 12,219.3 1.324상승
2024.01.24 12,070 -1.549하락 12,059.52 -1.549하락
2024.01.23 12,260 1.196상승 12,249.38 1.238상승
2024.01.22 12,115 1.849상승 12,099.53 1.810상승

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares
/ Par value
Weight(%) Market price (KRW)
1 HLB KR7028300002 1,437 17.37 114,097,800
2 SAMSUNG BIOLOGICS KR7207940008 83 10.34 67,894,000
3 Celltrion KR7068270008 317 8.68 57,028,300
4 Yuhan KR7000100008 754 7.47 49,085,400
5 HanmiPharm KR7128940004 102 5.31 34,884,000
6 SKBP KR7326030004 367 4.97 32,663,000
7 Celltrionph KR7068760008 258 4 26,238,600
8 SKBS KR7302440003 286 2.83 18,590,000
9 HANALL BIOPHARMA KR7009420001 475 2.56 16,791,250
10 Hanmi Science KR7008930000 366 2.37 15,573,300
11 MedyTox KR7086900008 73 2.08 13,687,500
12 SCD KR7000250001 188 1.95 12,821,600
13 CHONGKUNDANG KR7185750007 111 1.89 12,398,700
14 SEEGENE KR7096530001 432 1.71 11,210,400
15 DENTIUM KR7145720009 89 1.53 10,021,400
16 CHA Biotech KR7085660009 536 1.48 9,712,320
17 GC Corp KR7006280002 74 1.33 8,709,800
18 ST Pharm KR7237690003 135 1.29 8,491,500
19 BIONEER KR7064550007 299 1.2 7,908,550
20 PharmaResearch KR7214450009 83 1.16 7,594,500
21 HK inno.N KR7195940002 191 1.16 7,611,350
22 CLASSYS KR7214150005 232 1.12 7,342,800
23 DAEWOONG PHARM KR7069620003 61 1.11 7,259,000
24 HLBPHARMA KR7047920004 345 1.02 6,682,650
25 JWPHARMA KR7001060003 180 0.99 6,534,000
26 Daewoong KR7003090008 265 0.96 6,307,000
27 SD Biosensor KR7137310009 481 0.95 6,228,950
28 i-SENS KR7099190001 281 0.95 6,252,250
29 Jeisys Medical KR7287410005 717 0.94 6,159,030
30 ShinpoongPharm KR7019170000 446 0.9 5,909,500
31 DongKook Pharm KR7086450004 313 0.88 5,774,850
32 원화예금 KRD010010001 5,765,818 0.88 5,765,818
33 WONTECH KR7336570007 571 0.78 5,139,000
34 Boryung KR7003850005 398 0.75 4,935,200
35 Donga ST KR7170900005 68 0.74 4,875,600
36 GC CELL KR7144510005 107 0.63 4,162,300
37 Amicogen KR7092040005 603 0.58 3,780,810
38 ILDONG PHARM KR7249420001 225 0.55 3,615,750
39 INTEROJO KR7119610004 109 0.54 3,520,700
40 KwangdongPharm KR7009290008 426 0.51 3,318,540
41 Huons KR7243070000 89 0.5 3,297,450
42 HUMASIS KR7205470008 1,516 0.42 2,774,280
43 Ray KR7228670006 150 0.39 2,544,000
44 Aprogen KR7007460009 1,753 0.24 1,586,465
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.